logo-loader

Byotrol reassures over earnings and new markets

Published: 05:22 25 Feb 2016 EST

shutterstock_158005148-crop
Byotrol could soon claim to offer 24hr anti-microbial protection.

Shares in Byotrol (LON:BYOT) advanced on Thursday morning as the hygiene products company updated on its efforts to open-up new markets and reassured over it second half results.

Byotrol’s food related business is currently in hiatus, due to regulatory changes relating to the use of quaternary ammonium compounds, the company expects the shortfall in earnings will be mitigated by research and development tax credits due to the company.

The company added that the working capital position is ‘entirely adequate’ for its future needs.

"The board has never been more positive about the opportunities and our work load has never been higher,” said Nicholas Martel, Byotrol chairman.

“Our executive team have positioned Byotrol to be a completely different Company over a period of only two years, whilst overcoming the dislocation to the legacy business from the changing EU regulations.”

Martel highlighted that most of the group’s development efforts have been focussed at the consumer products market and it is now engaged with ‘some of the most prominent consumer companies worldwide.”

Specifically, he says the company is viewed in the industry as experts in long lasting anti-microbial technology.

Currently, Byotrol is working through the regulatory process in the United States to secure Environmental Protection Agency (EPA) approval.

Should approval be granted, the company will be able to claim its products offer ‘24 hour anti-microbial protection. Byotrol says it would, to its knowledge, be the only company to have this kind of product registration.

The company highlighted that it has already passed the toughest of the EPA tests, and remaining tests are now scheduled for the summer.

Talks are already underway to commercialise the patented technology, it added.

Byotrol is also partnered with Solvay, and the company said a number of the Belgian chemicals firm’s multinational clients are now testing and conducting research for possible consumer product launches. As part of this, a small number of high level commercial discussions are underway, it added.

Elsewhere, a product test is planned by the end of this month for application on hospital wards, and the results of that programme would be due in April.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

3 hours, 59 minutes ago